DOMAIN PARTERS VII L P

Average Profitability
89.57%
Insider Buys Quantity
4
Insider Buys Sum
$31.87M
Insider Sells Quantity
13
Insider Sells Sum
$5.21M

Insider Activity of DOMAIN PARTERS VII L P

The largest purchase of all time was on 2014-10-21 and amounted to 1000000 shares of Esperion Therapeutics, Inc. for $20M.

The largest sale of all time was on 2016-05-26 and amounted to 688240 shares of Evoke Pharma, Inc. for $3.23M.

Biography of DOMAIN PARTERS VII L P

No biography is available at this moment.

2019-08-06PurchaseReShape Lifesciences Inc.
RSLS
10 percent owner
250,000
0.9492%
$4.00$1M-47.08%
2018-08-23PurchaseReShape Lifesciences Inc.
RSLS
10 percent owner
1.65M
1.0347%
$1.82$3M-36.09%
2016-05-26SaleEvoke Pharma, Inc.
EVOK
10 percent owner
688,240
8.3615%
$4.70$3.23M-52.42%
2016-04-27SaleEvoke Pharma, Inc.
EVOK
10 percent owner
7,206
0.1042%
$5.02$36,174-46.99%
2016-04-25SaleEvoke Pharma, Inc.
EVOK
10 percent owner
2,984
0.0409%
$5.20$15,517-51.43%
2016-04-20SaleEvoke Pharma, Inc.
EVOK
10 percent owner
8,848
0.1254%
$5.29$46,806-50.19%
2016-04-19SaleEvoke Pharma, Inc.
EVOK
10 percent owner
74,108
1.0666%
$5.36$397,219-50%
2016-04-11SaleEvoke Pharma, Inc.
EVOK
10 percent owner
8,696
0.1207%
$5.22$45,393-50.1%
2016-04-08SaleEvoke Pharma, Inc.
EVOK
10 percent owner
29,108
0.4165%
$5.35$155,728-50.19%
2016-04-07SaleEvoke Pharma, Inc.
EVOK
10 percent owner
55,562
0.7583%
$5.26$292,256-51.31%
2016-04-06SaleEvoke Pharma, Inc.
EVOK
10 percent owner
17,338
0.2416%
$5.22$90,504-49.9%
2015-08-18SaleEvoke Pharma, Inc.
EVOK
10 percent owner
23,672
0.5007%
$7.02$166,177-28.63%
2015-04-16SaleEvoke Pharma, Inc.
EVOK
10 percent owner
64,822
1.1076%
$7.07$458,292-41.52%
2015-04-15SaleEvoke Pharma, Inc.
EVOK
10 percent owner
15,840
0.2598%
$7.58$120,067-47.58%
2015-04-14SaleEvoke Pharma, Inc.
EVOK
10 percent owner
19,664
0.3137%
$7.78$152,986-50.32%
2014-10-21PurchaseEsperion Therapeutics, Inc.
ESPR
10 percent owner
1M
5.3572%
$20.00$20M+170.46%
2013-07-01PurchaseEsperion Therapeutics, Inc.
ESPR
10 percent owner
561,846
3.6611%
$14.00$7.87M+8.67%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.